Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons

Published:2024-02-20 Issue:1-3 Volume:17 Page:9-25
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Seguí Inés Gómez¹,Mingot Castellano María Eva²,Izquierdo Cristina Pascual³,de la Rubia Javier¹⁴^ORCID

Affiliation:

1. Hematology Department institution, H. Universitario y Politécnico La Fe, Valencia, Valencia, Spain

2. Hospital Universitario Virgen del Rocío, Hematology Department, Sevilla, Spain

3. Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain

4. Internal Medicine, Universidad Católica “San Vicente Mártir”, Valencia, Spain

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2024.2318347

Reference127 articles.

1. An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

2. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura

3. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

4. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012

5. Predictors of In-hospital Mortality and Acute Myocardial Infarction in Thrombotic Thrombocytopenic Purpura

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura;Biomedicines;2024-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3